Company Analysis

Amarin Corporation plc (AMRN)

Nasdaq: AMRN · Pharmaceutical Preparations · Dublin 2 · filing with the SEC since 1998
Grade4.9
◀ Past 4.9● Present 5.2▶ Future 4.7
1 est.

Who runs Amarin Corporation plc

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Berg Aaron
President and CEO. First filing Mar 2019, latest Jun 30, 2026, 4 filings in all.
Officers reporting now
5
of 12 people with a filing in the last fifteen months
Directors reporting now
7
36 people on the record since 2010
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Fishman Peter L.SVP, CFOOct 2024Aug 3, 2026none
Keenan David PaulEVP, Chief Operating OfficerOct 2025Jul 15, 2026none
Ketchum Steven BEVP, Chief Scientific OfficerFeb 2012Jul 15, 2026none
Provoost JonathanEVP, Chief Legal OfficerNov 2023Jul 15, 2026none
Berg AaronPresident and CEOMar 2019Jun 30, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Bonfiglio Patrice EadondirectorMar 2023Apr 22, 2026none
Cohen PauldirectorMar 2023Apr 21, 2026none
Horn KeithdirectorMar 2023Apr 21, 2026none
O'Connor OliverdirectorApr 2023Apr 21, 2026none
Odysseas Kostas DdirectorMar 2023Apr 21, 2026none
Sterling Louis IIIdirectorMar 2023Apr 21, 2026none
Sullivan Diane E.directorMar 2023Apr 21, 2026none
Earlier names on the record24, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton AMRN · research, not advice